Arcutis Biotherapeutics EVP, CLO Masaru Matsuda Sells $1.41M of Stock
Masaru Matsuda, EVP, CLO, sold 41,219 shares of Arcutis Biotherapeutics, Inc. at $31.86 to $34.32 a share (average $34.24) in 2 transactions, worth $1.41M in total between Nov 2, 2026 and Nov 4, 2026. Shares held after the trade: 111,289 (-26.4%).
Arcutis Biotherapeutics EVP, CMO Patrick Burnett Sells $30K of Stock
Patrick Burnett, EVP, CMO, sold 943 shares of Arcutis Biotherapeutics, Inc. at $31.86 a share, worth $30K in total on Nov 2, 2026. Shares held after the trade: 116,649 (-0.8%).
Arcutis Biotherapeutics Insider Todd Watanabe Sells $139K of Stock
Todd Watanabe sold 4,377 shares of Arcutis Biotherapeutics, Inc. at $31.86 a share, worth $139K in total on Nov 2, 2026. Shares held after the trade: 712,826 (-0.6%).
Arcutis Biotherapeutics Insider Howard G. Welgus Sells $127K of Stock
Howard G. Welgus sold 4,728 shares of Arcutis Biotherapeutics, Inc. at $26.93 a share, worth $127K in total on Oct 15, 2026. Shares held after the trade: 35,207 (-11.8%).
Arcutis Biotherapeutics Insider Masaru Matsuda Sells $91.9K of Stock
Masaru Matsuda sold 3,674 shares of Arcutis Biotherapeutics, Inc. at $25.00 a share, worth $91.9K in total on Sep 16, 2026. Shares held after the trade: 112,508 (-3.2%).